{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:04:31Z","timestamp":1780315471090,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020684","name":"University of Calgary Arnie Charbonneau Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtct.2025.12.993","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:25:53Z","timestamp":1766247953000},"page":"613.e1-613.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings"],"prefix":"10.1016","volume":"32","author":[{"given":"Dylan E.","family":"O\u2019Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Blosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Crisp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljit","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Bista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Beda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Shafey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-2677","authenticated-orcid":false,"given":"Kevin","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-6598","authenticated-orcid":false,"given":"Robert","family":"Puckrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-9122","authenticated-orcid":false,"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-522X","authenticated-orcid":false,"given":"Kareem","family":"Jamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2025.12.993_bib0001","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbmt.2016.11.004","article-title":"Long-term survivorship after hematopoietic cell transplantation: roadmap for research and care","volume":"23","author":"Battiwalla","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"10.1016\/j.jtct.2025.12.993_bib0002","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.993_bib0003","doi-asserted-by":"crossref","first-page":"768e1","DOI":"10.1016\/j.jtct.2023.09.010","article-title":"Improved long-term net survival after allogeneic hematopoietic cell transplantation in patients with hematologic malignancies over two decades","volume":"29","author":"Ohbiki","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.993_bib0004","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jtct.2025.05.010","article-title":"To save a life - if you save a life, then you are responsible for that life","volume":"31","author":"Bhatia","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"17","key":"10.1016\/j.jtct.2025.12.993_bib0005","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the bone marrow transplant survivor study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.993_bib0006","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"28","key":"10.1016\/j.jtct.2025.12.993_bib0007","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.21.02829","article-title":"Burden of long-term morbidity borne by survivors of acute myeloid leukemia treated with blood or marrow transplantation: the results of the BMT survivor study","volume":"40","author":"Armenian","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.993_bib0008","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2004.00402.x","article-title":"Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls","volume":"74","author":"Kopp","year":"2005","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.993_bib0009","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2002.06.077","article-title":"Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation","volume":"20","author":"Kiss","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.993_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","article-title":"Quality of life after allogeneic hematopoietic cell transplantation","volume":"114","author":"Pidala","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.993_bib0011","doi-asserted-by":"crossref","first-page":"409e1","DOI":"10.1016\/j.jtct.2022.04.012","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.12.993_bib0012","article-title":"Acute graft versus host disease 1976-2020: reduced incidence and predictive factors","volume":"10","author":"Di Francesco","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"22","key":"10.1016\/j.jtct.2025.12.993_bib0013","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1182\/bloodadvances.2024012722","article-title":"Decreasing chronic graft-versus-host disease rates in all populations","volume":"8","author":"Carpenter","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.993_bib0014","doi-asserted-by":"crossref","first-page":"701e1","DOI":"10.1016\/j.jtct.2022.07.018","article-title":"Health-related quality of life in young adult survivors of hematopoietic cell transplantation","volume":"28","author":"Rotz","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.993_bib0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cncr.31089","article-title":"PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors","volume":"124","author":"Shaw","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2025.12.993_bib0016","unstructured":"Meaningful Change for PROMIS 2025 Available at: https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis\/meaningful-change. Accessed February 1, 2025."},{"issue":"1","key":"10.1016\/j.jtct.2025.12.993_bib0017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41409-020-01017-8","article-title":"Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health","volume":"56","author":"Wolff","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.993_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14018","article-title":"Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulin","volume":"34","author":"Ousia","year":"2020","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.993_bib0019","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.34575","article-title":"Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood","volume":"129","author":"Holmqvist","year":"2023","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.993_bib0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jts.2490090305","article-title":"The posttraumatic growth inventory: measuring the positive legacy of trauma","volume":"9","author":"Tedeschi","year":"1996","journal-title":"J Trauma Stress"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.993_bib0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s40359-023-01204-4","article-title":"Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey","volume":"11","author":"McErlean","year":"2023","journal-title":"BMC Psychol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.993_bib0022","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbmt.2017.12.785","article-title":"Transplant conditioning with treosulfan\/fludarabine with or without total body irradiation: a randomized phase II trial in patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"24","author":"Deeg","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2025.12.993_bib0023","first-page":"3031","article-title":"Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","volume":"141","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.993_bib0024","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400192","article-title":"Haploidentical bone marrow transplantation for sickle cell disease","volume":"4","author":"Kassim","year":"2025","journal-title":"NEJM Evid"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.993_bib0025","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3324\/haematol.2018.192930","article-title":"Patient-reported outcomes and health status associated with chronic graft-versus-host disease","volume":"103","author":"Lee","year":"2018","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.993_bib0026","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the bone marrow transplant survivor study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.993_bib0027","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cjco.2024.05.012","article-title":"Prevalence, patient awareness, treatment, and control of hypertension in Canadian adults with common comorbidities","volume":"6","author":"Leung","year":"2024","journal-title":"CJC Open"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672502651X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672502651X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:08:15Z","timestamp":1780312095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672502651X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S266663672502651X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.993","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}